in this issue
Regions :: Western Europe :: Switzerland
Lonza Forms Commercial Partnership with Israeli Firm
12:23 AM MDT | October 11, 2011 | Deepti Ramesh
Lonza says it has formed a global commercial partnership with phosphatidyl serine manufacturer Lipogen (Haifa, Israel) for the exclusive rights to sell phosphatidyl serine and phosphatidyl serine-based formulations in dietary supplements, medical foods, and food and beverages. The products will be branded and sold under the Lonza name. Lonza intends to roll out launch activities in the U.S. in this quarter, and expand to other regions thereafter. Phosphatidyl serine, which may reduce the risk of dementia and cognitive dysfunction in the elderly as well as reduce...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: